USHIO (6925) FY2026 Q3 Earnings Report

Quick View

Executive Summary

While revenue declined 0.9% YoY, operating income increased 4.6%; however, net income fell substantially due to extraordinary losses and a high tax burden. Revenue was ¥126.95B (-0.9% YoY), operating income was ¥7.73B (+4.6%), ordinary income was ¥8.88B (-15.1%), and net income was ¥4.04B (-29.7%). Improvement in profitability at the operating level was offset at the net income level by ¥4.86B in extraordinary losses, including ¥4.10B in business-structure improvement expenses, and a high effective tax rate of 46.8%.

Factors Affecting Earnings

【Revenue】Revenue was ¥126.95B, down 0.9% YoY. By segment, the core VisualImaging segment was essentially flat at ¥60.59B (47.7% of total, +0.3% YoY), while IndustrialProcesses declined to ¥52.95B (41.7% of total, -3.1% YoY). PhotonicsSolutions increased to ¥7.68B (+0.8%), and LifeSciences rose to ¥4.74B (+5.5%), both achieving growth despite their smaller scale. Overall, revenue remained broadly flat as growth in the two smaller businesses offset the performance of the two core businesses.

【Profit and Loss】Operating income was ¥7.73B (+4.6% YoY), and the operating margin improved to 6.1% from the previous year. By segment, the profit margin of IndustrialProcesses declined substantially, while VisualImaging expanded its profit contribution and LifeSciences and PhotonicsSolutions returned to profitability. Ordinary income slowed to ¥8.88B (-15.1%), affected by non-operating expenses including a ¥0.51B foreign exchange loss. At the net income level, extraordinary losses of ¥4.86B, mainly consisting of ¥4.10B in business-structure reform expenses, exceeded extraordinary gains of ¥3.57B, including a ¥3.53B gain on the sale of investment securities. After recording a net extraordinary loss of ¥1.29B, net income was ¥4.04B (-29.7% YoY). The high effective tax rate of 46.8% also weighed on net income. Although the company experienced a revenue decline and operating-income growth rather than revenue growth and profit decline, the ordinary income and net income levels showed the appearance of declining revenue and earnings.

Segment Analysis

IndustrialProcesses reported revenue of ¥52.95B (41.7% of total), operating income of ¥3.81B, and a 7.2% profit margin. Its profit margin declined substantially from the previous year, becoming a drag on consolidated earnings. VisualImaging reported revenue of ¥60.59B (47.7% of total), operating income of ¥3.57B, and a 5.9% profit margin; its improved margin from the previous year was the primary driver of operating-income growth. PhotonicsSolutions reported revenue of ¥7.68B, operating income of ¥0.24B, and a 3.2% profit margin, while LifeSciences reported revenue of ¥4.74B, operating income of ¥0.21B, and a 4.4% profit margin. Both segments returned to profitability. Profitability varies significantly among the core businesses, and demand and pricing trends in IndustrialProcesses will determine consolidated earnings going forward.

Key Financial Indicators

【Profitability】The operating margin was 6.1%, the net profit margin was 3.2%, and the ordinary income margin was 7.0%. Profitability improved at the operating level from the previous year but declined at the net income level. The gross margin was 36.7% and the SG&A ratio was 30.6%; the company secured operating-income growth through SG&A control despite the absence of revenue growth.【Cash Flow Quality】Comprehensive income of ¥18.11B substantially exceeded net income of ¥4.04B, with OCI from foreign currency translation adjustments of ¥7.24B and valuation differences on securities of ¥7.03B increasing net assets. The gap between net income and comprehensive income primarily reflects valuation- and translation-related items and does not directly represent recurring business earning power.【Investment Efficiency】ROE was 2.0% and the Equity Ratio was 62.8%. Although financial soundness is high, there is room to improve capital efficiency. Total asset turnover remained low, making improvement in asset efficiency a future issue.【Financial Soundness】Cash and deposits of ¥70.13B substantially exceeded interest-bearing debt, resulting in a net cash position. Current assets of ¥197.83B substantially exceeded current liabilities of ¥76.65B. The Equity Ratio declined to 62.8% from 67.4% in the previous year but remained at a high level.

Cash Flow Analysis

Although detailed disclosure of the statement of cash flows is unavailable, changes in the balance sheet indicate that cash and deposits were ¥70.13B, an increase of ¥8.78B from ¥61.35B in the previous year. Property, plant and equipment was ¥50.08B and investment securities were ¥43.96B, both increasing from the previous year, indicating continued allocation of funds to capital expenditure and securities investments. Long-term borrowings were ¥26.50B, down from ¥35.00B in the previous year, indicating progress in reducing interest-bearing debt. Inventories were ¥30.96B, slightly up from ¥30.42B in the previous year, and the increase in working capital may have affected capital efficiency. Overall, cash accumulation and interest-bearing debt reduction are progressing in parallel, strengthening the conservativeness of the financial foundation.

Quality of Earnings

The current period’s earnings include a meaningful amount of temporary factors, requiring caution when evaluating earnings quality. Most of the ¥3.57B in extraordinary gains consisted of the non-recurring ¥3.53B gain on the sale of investment securities, while the ¥4.86B in extraordinary losses mainly comprised one-off expenses, including ¥4.10B in business-structure reform expenses. The net extraordinary loss of ¥1.29B directly reduced net income and was the primary cause of the gap between ordinary income of ¥8.88B and net income of ¥4.04B. In non-operating income and expenses, dividends received of ¥0.65B and interest income of ¥0.96B contributed to recurring income, while a foreign exchange loss of ¥0.51B was recorded as an expense, making non-operating results a source of volatility. The effective tax rate was high at 46.8%, and the heavy tax burden also reduced the quality of net income. The gap between comprehensive income of ¥18.11B and net income of ¥4.04B resulted from valuation-related OCI items such as foreign currency translation adjustments and valuation differences on securities and does not represent the company’s underlying recurring earning power.

Earnings Forecast and Guidance

Progress against the full-year company forecast was 74.7% for revenue, 77.3% for operating income, 84.5% for ordinary income, and 57.7% for net income. While progress for revenue and operating income was above or approximately in line with the standard 75% level, net income progress was substantially lower. Extraordinary losses and the high tax burden recorded through Q3 cumulative results are constraints on achieving the full-year net income forecast of ¥7.00B. The full-year forecasts are revenue of ¥170.00B (-4.3% YoY), operating income of ¥10.00B (+13.3%), and ordinary income of ¥10.50B (-15.7%). Continued improvement in operating income in the second half is a prerequisite for achieving the plan.

Shareholder Returns

The full-year dividend forecast is ¥70.00 per share, implying a Payout Ratio of approximately 88.1% against forecast EPS of ¥79.45. This Payout Ratio uses dividends alone as the numerator and is distinct from the Total Return Ratio, which includes share repurchases. With net income progress at only 57.7%, realization of the annual dividend depends on earnings recovery in Q4. However, the financial foundation of net cash—with cash and deposits of ¥70.13B substantially exceeding interest-bearing debt of ¥27.97B—supports the dividend.

Risk Factors

1. Deterioration in profitability of the core business: Revenue in the IndustrialProcesses Business declined 3.1% YoY, while its profit margin also fell substantially from the previous year, and continued downward pressure on consolidated earnings remains.

2. Working capital tied up: Inventories of ¥30.96B and accounts receivable of ¥35.90B represent substantial asset balances. A lengthening of inventory and receivables collection cycles could affect capital efficiency and the risk of valuation losses.

3. High tax burden and potential recurrence of extraordinary losses: In addition to the effective tax rate of 46.8%, extraordinary losses of ¥4.86B, including ¥4.10B in business-structure reform expenses, reduced net income. If similar non-recurring items arise in the future, they may become a source of volatility in bottom-line earnings.

Industry Benchmark (Reference; Company Analysis)

Industry Benchmark (manufacturing)

Profitability and Returns

The company’s profitability is below the industry median, with both its operating and net profit margins relatively low within the industry.

Growth and Capital Efficiency

The revenue growth rate is also below the industry median, indicating a declining revenue trend compared with peers.

※Source: Company analysis

Key Points from the Earnings Results

1. The operating margin of 6.1% improved from the previous year. The results indicate that improved profitability at VisualImaging and the return to profitability of LifeSciences and PhotonicsSolutions partially offset the decline in IndustrialProcesses’ profit margin.

2. Ordinary income and net income did not fully reflect the improvement at the operating level due to extraordinary losses including ¥4.10B in business-structure reform expenses and the high effective tax rate of 46.8%.

3. The financial foundation of net cash and high equity capital—cash and deposits of ¥70.13B and an Equity Ratio of 62.8%—indicates financial capacity to pursue future business restructuring and working-capital improvement.

Theoretical Share Price (Reference Value)

Sensitivity: ¥2,004–¥2,116 at ±1% for the cost of equity, and ¥2,047–¥2,066 at ±0.1 for ω.

Notes:

• Because forecast ROE is below the cost of equity, the theoretical value is below book value per share.
• Net assets as of the quarter-end are used (there is a timing difference relative to the full-year forecast).
• Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / This is a mechanically calculated value based solely on publicly available data; it is not a forecast of the market share price or a recommendation of any specific investment action, and does not forecast or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting professionals as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

Ushio Electric’s FY2026 Q3 cumulative result showed resilient operating profitability despite a modest sales decline, but below-the-line restructuring and impairment charges materially reduced net income. Revenue declined 0.9% year on year to ¥126.95bn. Operating income nevertheless rose 4.6% to ¥7.73bn. The operating margin improved by 32bp to 6.1% from 5.8% in the prior-year period. Gross profit margin was broadly stable at 36.7%, up approximately 4bp year on year. SG&A expense declined 1.8% to ¥38.84bn, a faster reduction than the decline in revenue, supporting operating-margin expansion. Industrial Process remained the core business by segment profit contribution, generating ¥3.81bn of segment profit. However, Industrial Process profit fell 46.3% year on year, offsetting much of the strong recovery in Visual Imaging. Visual Imaging segment profit increased 145.1% to ¥3.57bn, with revenue increasing 0.3% to ¥60.58bn. Life Science and Photonics Solution both returned to segment profitability from losses in the prior-year period. Ordinary income fell 15.1% to ¥8.88bn because non-operating income declined while non-operating expenses rose. Net income attributable to owners fell 29.8% to ¥4.04bn, and EPS declined to ¥47.25. The effective tax rate was elevated at 46.8%, reducing the conversion of pre-tax profit into net profit. Exceptional items were also a major drag: a ¥3.53bn gain on sale of investment securities was more than offset by ¥4.86bn of extraordinary losses, including ¥4.10bn of restructuring costs and ¥0.39bn of impairment loss. Comprehensive income rose sharply to ¥18.11bn, supported principally by gains in foreign-currency translation and valuation differences on securities rather than operating earnings. Management’s full-year operating-income forecast of ¥10.00bn implies that the company is broadly on track operationally, while the full-year net-income target requires a substantial Q4 contribution. The financial position remains highly liquid, with cash of ¥70.13bn and a current ratio of 258.1%. The principal investment debate is therefore not balance-sheet resilience, but whether the Visual Imaging recovery can sustainably offset Industrial Process weakness and lift low capital returns.

Profitability Analysis

The annualized DuPont ROE is 2.7%, comprising a 3.2% net profit margin, 0.537x asset turnover and 1.59x financial leverage. The low net margin is the principal constraint on shareholder returns, rather than an aggressive capital structure. Financial leverage is moderate and does not materially amplify either returns or balance-sheet risk. The 6.1% EBIT margin is below the 8% level generally associated with strong industrial profitability, although it improved from approximately 5.8% in the prior-year period. Gross margin remained stable at 36.7%, indicating that the operating-margin improvement was predominantly generated by SG&A discipline rather than a major improvement in product mix or manufacturing gross profitability. SG&A fell 1.8% while revenue fell 0.9%, demonstrating positive operating leverage. Segment performance was highly divergent. Industrial Process was the core business by segment profit, contributing ¥3.81bn, or roughly 49% of consolidated operating income, but its segment margin compressed to 7.2% from 13.0% and profit declined ¥3.29bn. Visual Imaging produced ¥3.57bn of segment profit, a margin of 5.9%, versus ¥1.46bn and 2.4% previously; its ¥2.11bn profit increase was the largest positive earnings movement. Life Science improved to a ¥0.21bn profit from a ¥0.80bn loss, while Photonics Solution improved to a ¥0.24bn profit from a ¥0.33bn loss. The improvement in Visual Imaging and the return to profitability of smaller businesses support the operating result, but Industrial Process deterioration indicates that the recovery is not yet broad-based. The annualized asset turnover of 0.537x remains modest for a manufacturing company and, together with the 3.5% reported ROIC alert, indicates that the asset base is generating inadequate operating returns. The 46.8% effective tax rate produced a tax burden of 0.532, well below the 0.70 normal benchmark and materially constrained net-income conversion. Interest burden remained healthy at 0.981 and interest coverage was strong at 28.54x, confirming that financing cost is not the reason for the weak ROE.

Growth Assessment

Revenue declined 0.9% to ¥126.95bn, reflecting a ¥1.67bn decline in Industrial Process revenue to ¥52.95bn. Visual Imaging revenue increased 0.3% to ¥60.58bn and became the largest segment by sales. Life Science revenue grew 5.5% to ¥4.74bn, while Photonics Solution revenue increased 0.8% to ¥7.68bn. The segment mix is improving in the sense that Visual Imaging’s profit recovery and the elimination of losses in Life Science and Photonics Solution raised consolidated operating income despite lower sales. However, the sharp contraction in Industrial Process profit indicates that growth quality remains dependent on the durability of the Visual Imaging improvement. Full-year guidance calls for revenue of ¥170.00bn, down 4.3% year on year, and operating income of ¥10.00bn, up 13.3%. Q3 revenue progress is 74.7% of the full-year forecast, essentially in line with the standard 75% Q3 progress rate. Operating-income progress is 77.3%, 2.3 percentage points ahead of the standard pace. Ordinary-income progress is 84.5%, 9.5 percentage points ahead of the standard pace, although it remains just within the 10-percentage-point deviation threshold. Net-income progress is only 57.7% of the ¥7.00bn full-year target, 17.3 percentage points below the standard Q3 pace because of the cumulative exceptional-loss and tax burden. Achieving guidance requires Q4 revenue of ¥43.05bn, operating income of ¥2.27bn, ordinary income of ¥1.62bn and net income attributable to owners of ¥2.96bn. The required Q4 net income is therefore substantial relative to cumulative Q3 earnings and makes normalization of exceptional charges and tax outcomes important.

Financial Health

Liquidity is strong, with current assets of ¥197.83bn against current liabilities of ¥76.65bn, producing a current ratio of 258.1%. The quick ratio is also robust at 217.7%, supported by ¥70.13bn of cash and deposits and ¥35.90bn of trade receivables. Working capital totals ¥121.18bn. Interest-bearing debt is ¥27.97bn, equivalent to 0.59x equity on the reported debt-to-equity measure, while debt-to-capital is only 12.4%. Cash covers short-term debt by 47.67x, and the short-term debt ratio is only 5.3%, indicating very limited near-term refinancing pressure. Interest coverage of 28.54x provides a substantial earnings cushion against higher financing costs. Long-term loans of ¥26.50bn represent the principal interest-bearing obligation, while short-term loans are only ¥1.47bn. The balance sheet is also supported by ¥43.96bn of investment securities, equal to 14.0% of total assets. Total equity declined ¥2.63bn year on year to ¥197.88bn, but this reflects capital allocation effects despite ¥14.07bn of other comprehensive income; owners’ equity remains 62.8% of total assets. Treasury stock increased in absolute amount by ¥14.51bn year on year to negative ¥22.18bn, reducing reported equity and increasing the importance of disciplined capital allocation. Goodwill is only ¥0.58bn, or 0.3% of equity, and intangible assets are 1.5% of assets, leaving negligible M&A-related impairment dependence. Asset retirement obligations are ¥0.37bn, equivalent to approximately 0.3% of total liabilities, indicating limited environmental-obligation exposure on the balance sheet.

Notable B/S Changes

Treasury stock: increased by ¥14.51bn to negative ¥22.18bn (-189.1% year on year) - a material reduction in reported equity that raises the relevance of capital-allocation discipline and total shareholder-return assessment. Investment securities: increased by ¥6.49bn to ¥43.96bn (+17.3%) - securities now represent 14.0% of total assets and contribute to exposure to market-value movements. Long-term loans: decreased by ¥8.50bn to ¥26.50bn (-24.3%) - lower long-term borrowing strengthens an already conservative funding profile. Current portion of long-term loans: increased by ¥23.59bn to ¥25.00bn - cash of ¥70.13bn provides substantial coverage of the scheduled near-term debt maturity. Trade receivables: decreased by ¥4.42bn to ¥35.90bn (-10.9%) - the lower balance is positive for capital deployment, while the reported 77-day receivable alert remains a collection-efficiency focus. Deferred tax liabilities: increased by ¥4.34bn to ¥7.54bn (+135.4%) - the movement is consistent with higher unrealized valuation gains, which also contributed to comprehensive income. Foreign-currency translation adjustment: increased by ¥7.24bn to ¥39.54bn (+22.4%) - currency translation was a major contributor to the ¥14.07bn increase in other comprehensive income.

Cash Flow Quality

The company’s cash liquidity is substantial, with cash and deposits of ¥70.13bn, but cash-flow-based earnings-conversion metrics are not included in the reported period data.

Dividend Sustainability

The full-year dividend forecast is ¥70 per share. Against forecast EPS of ¥79.45, the implied dividend payout ratio is approximately 88.1%. This is above the 60% benchmark generally associated with conservatively sustainable dividend coverage, although the company’s strong liquidity and low debt burden provide financial capacity. The payout ratio should be assessed alongside the weak annualized ROE of 2.7% and reported ROIC of 3.5%, as shareholder distributions are being made while operating capital efficiency remains low. Treasury stock increased by ¥14.51bn year on year, indicating a meaningful reduction in reported equity through treasury-share accumulation. A total return ratio cannot be calculated from the available data. The full-year net-income forecast of ¥7.00bn, rather than the stronger operating-income forecast, is the key earnings base supporting the dividend. Sustainability will therefore depend on delivery of the required Q4 net income and containment of restructuring, impairment and tax effects.

Risk Assessment

Business risks include Industrial Process revenue declined 3.1% year on year and segment profit declined 46.3% to ¥3.81bn, with margin falling from 13.0% to 7.2%; a prolonged weakness in this core profit contributor would pressure consolidated margins., Visual Imaging generated a ¥2.11bn year-on-year segment-profit increase and now underpins the operating-income improvement; earnings are increasingly sensitive to whether this recovery is sustained., Manufacturing working-capital alerts show receivable days of 77 days, above the 60-day warning level, indicating slower cash collection and potential customer-demand or collection-cycle risk., Inventory-day alerts of 265 days and 105 days both exceed their respective warning thresholds. These signals indicate elevated inventory holding risk, including slower inventory conversion, demand forecasting error and potential obsolescence exposure., The reported cash conversion cycle of 280 days is substantially above the 120-day warning level, indicating a long operating cash cycle and heightened sensitivity to changes in demand, production planning and customer collections., As an optical-equipment manufacturer, the group is exposed to technology-cycle, customer capital-expenditure and product-transition risk, particularly across industrial processing, visual imaging and photonics applications., Foreign-exchange losses were ¥0.51bn in the period, demonstrating exposure to currency movements that can affect reported non-operating profit..

Financial risks include The high-tax-burden alert is material: the 46.8% effective tax rate reduced the tax burden to 0.532, below the 0.60 warning threshold, and materially weakened conversion from pre-tax income to net income., The capital-efficiency alert is material: reported ROIC of 3.5% is below the 5% warning threshold, while annualized ROE is only 2.7%. This limits the rate at which retained capital can compound shareholder value., Net income attributable to owners fell 29.8% to ¥4.04bn despite a 4.6% increase in operating income, illustrating exposure to non-operating, exceptional and tax volatility., Extraordinary losses of ¥4.86bn exceeded extraordinary gains of ¥3.57bn, including ¥4.10bn of restructuring costs and ¥0.39bn of impairment loss, creating a material drag on earnings., The implied forecast dividend payout ratio is approximately 88.1%, leaving less earnings headroom than a payout ratio below 60%, even though liquidity and leverage are strong..

Key concerns include Priority high: Industrial Process margin compression is the most important operating risk because the segment remains the largest contributor to segment profit., Priority high: Long inventory and cash-conversion metrics may tie up capital and create future write-down risk if demand or product cycles weaken., Priority medium: The elevated tax burden and restructuring charges make net income materially less predictable than operating income., Priority medium: Low ROIC and ROE indicate that improved operating profit has not yet translated into adequate returns on the company’s substantial capital base., Priority medium: Full-year net-income guidance requires ¥2.96bn in Q4, making the year-end result sensitive to below-the-line items..

Investment Implications

Key takeaways include Operating income increased 4.6% and operating margin expanded 32bp to 6.1% despite a 0.9% sales decline., Visual Imaging’s segment-profit recovery was the principal positive driver, while Industrial Process experienced a significant earnings contraction., Balance-sheet liquidity is exceptionally strong, with ¥70.13bn of cash, a 258.1% current ratio and only 12.4% debt-to-capital., Low annualized ROE of 2.7% and reported ROIC of 3.5% remain the central capital-efficiency constraints., The full-year operating-income target is broadly on track, but net-income delivery depends on a strong Q4 and reduced below-the-line drag..

Metrics to watch include Industrial Process revenue growth and segment margin, Visual Imaging segment-profit margin and repeatability of its recovery, Receivable days, inventory days and the cash conversion cycle, Restructuring costs, impairment charges and effective tax rate, Q4 net income relative to the ¥2.96bn required to meet full-year guidance, ROIC, annualized ROE and the dividend payout ratio.

Regarding relative positioning, Ushio Electric is financially conservative relative to typical leveraged industrial companies, with strong liquidity, low debt-to-capital and immaterial goodwill exposure. Its operating margin is improving but remains below the 8% level typically associated with strong industrial profitability, while capital returns remain weak. Relative positioning is therefore defined by balance-sheet strength and recovering Visual Imaging profitability, offset by Industrial Process margin pressure and inefficient working-capital indicators.